Tolerability and discontinuation rates in teriflunomide-treated patients: A real-world clinical experience

Hind A. Alnajashi; Foziah J. Alshamrani; Mark S. Freedman

doi:10.17712/nsj.2018.3.20180003

Article Information

vol. 23 no. 3 204-207

DOI

https://doi.org/10.17712/nsj.2018.3.20180003

PubMed

30007995

Published By

Neurosciences Journal

Online ISSN

1658-3183

History

Received January 2, 2018
Accepted April 25, 2018
Published online November 13, 2020.

Copyright: © Neurosciences Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

Author Information

Hind A. Alnajashi, MD, SBN ⇑,
Foziah J. Alshamrani, MD, SBN and
Mark S. Freedman, HSBc, FRCPC

From the Neurology Division (Alnajashi), Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, from the Department of Neurology (Alshamrani), Imam Abdulrahman Bin Faisal University, King Fahad Hospital of the University, Dammam, and from the Neurology Division (Freedman) Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, Ottawa, Canada

Address correspondence and reprint request to: Dr. Hind Alnajashi, Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. E-mail: Hindnajashi{at}gmail.com ORCID ID: http://orcid.org/0000-0001-6096-3667

View Full Text